We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-16.73%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$300M
AUM Growth
-$39.4M
Cap. Flow
+$19.1M
Cap. Flow %
6.37%
Top 10 Hldgs %
40.88%
Holding
110
New
17
Increased
29
Reduced
31
Closed
33

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$15.1M
2
AET
Aetna Inc
AET
+$9.05M
3
LAB icon
Standard BioTools
LAB
+$7.23M
4
SPNC
Spectranetics Corp
SPNC
+$6.43M
5
STJ
St Jude Medical
STJ
+$5.86M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$9.99M
2
BCR
CR Bard Inc.
BCR
+$9.92M
3
ELV icon
Elevance Health
ELV
+$6.68M
4
WBA
Walgreens Boots Alliance
WBA
+$6.22M
5
ISRG icon
Intuitive Surgical
ISRG
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 88.86%
2 Financials 3.68%
3 Industrials 1.11%
4 Technology 1.01%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVA icon
51
DaVita
DVA
$15.4B
$1.45M 0.49%
20,100
+1,900
+10% +$147K
AMPH icon
52
Amphastar Pharmaceuticals
AMPH
$879M
$1.44M 0.48%
123,259
-10,300
-8% -$154K
JAZZ icon
53
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.4M 0.47%
10,500
-500
-5% -$86.1K
COR icon
54
Cencora
COR
$60.6B
$1.23M 0.41%
12,904
+300
+2% +$31.5K
ZVRA icon
55
Zevra Therapeutics
ZVRA
$562M
$1.22M 0.41%
3,921
-5,185
-57% -$1.59M
CAH icon
56
Cardinal Health
CAH
$53.9B
$1.21M 0.4%
+15,700
New +$1.31M
KTWO
57
DELISTED
K2M Group Holdings, Inc
KTWO
$1.18M 0.39%
63,433
-57,700
-48% -$1.26M
REGN icon
58
Regeneron Pharmaceuticals
REGN
$78.5B
$1.12M 0.37%
+2,400
New +$1.29M
SSRG
59
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
$1.11M 0.37%
124,804
+37,555
+43% +$323K
A icon
60
Agilent Technologies
A
$39.1B
$895K 0.3%
26,065
-37,600
-59% -$1.42M
ABBV icon
61
AbbVie
ABBV
$443B
$892K 0.3%
+16,400
New +$1.07M
ELOS
62
DELISTED
Syneron Medical Ltd
ELOS
$855K 0.29%
119,545
-210,369
-64% -$2.02M
TVTY
63
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$833K 0.28%
74,900
+54,900
+275% +$671K
BKD icon
64
Brookdale Senior Living
BKD
$3.49B
$792K 0.26%
+34,500
New +$1.02M
PTCT icon
65
PTC Therapeutics
PTCT
$5.68B
$614K 0.21%
23,000
-1,100
-5% -$47K
OCRX
66
DELISTED
Ocera Therapeutics, Inc.
OCRX
$560K 0.19%
177,121
-54,020
-23% -$208K
TRNX
67
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$479K 0.16%
23,468
-3,000
-11% -$72.1K
CRL icon
68
Charles River Laboratories
CRL
$11.2B
$413K 0.14%
+6,500
New +$467K
ALPN
69
DELISTED
Alpine Immune Sciences Inc
ALPN
$393K 0.13%
7,571
-4,054
-35% -$266K
EW icon
70
Edwards Lifesciences
EW
$49.6B
$384K 0.13%
16,200
-50,400
-76% -$1.22M
PTLA
71
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$371K 0.12%
+8,700
New +$420K
HOLX
72
DELISTED
Hologic
HOLX
$329K 0.11%
+8,400
New +$333K
ACAD icon
73
Acadia Pharmaceuticals
ACAD
$4.43B
$321K 0.11%
9,700
-5,300
-35% -$221K
RAD
74
DELISTED
Rite Aid Corporation
RAD
$240K 0.08%
1,975
-3,910
-66% -$651K
HTWR
75
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$209K 0.07%
+4,000
New +$304K
1 2
3
4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Endurant Capital Management held 110 positions worth $300M, down 12% from $339M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Endurant Capital Management deployed $19.1M of net new capital in Q3 2015, opening 17 new positions and adding to 29 existing holdings. Its largest new stake was AMAG Pharmaceuticals: 94,100 shares worth $3.74M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 90% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Labcorp, an estimated $9.99M trimmed.

  • Endurant Capital Management's largest Q3 2015 buy was AMAG Pharmaceuticals: 94,100 shares worth $3.74M.
  • Endurant Capital Management added most to MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2015, an estimated $15.1M increase.
  • Endurant Capital Management's biggest Q3 2015 reduction was Labcorp, cutting an estimated $9.99M.
  • Endurant Capital Management fully exited Elevance Health in Q3 2015, selling an estimated $6.68M.
  • Endurant Capital Management's ten largest holdings make up 41% of its $300M portfolio in Q3 2015.
  • Endurant Capital Management opened 17 new positions and closed 33 in Q3 2015.
  • Endurant Capital Management's portfolio value fell 12% quarter-over-quarter to $300M.

Based on Endurant Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.